These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Current status of adjuvant chemotherapy of invasive bladder cancer]. Ozono S; Sasaki K; Watanabe S; Maruyama Y; Ohara S; Babaya K; Yamada K; Hirao Y; Okajima E Hinyokika Kiyo; 1991 Dec; 37(12):1589-95. PubMed ID: 1785379 [TBL] [Abstract][Full Text] [Related]
10. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors. Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282 [TBL] [Abstract][Full Text] [Related]
11. Can patient selection for bladder preservation be based on response to chemotherapy? Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521 [TBL] [Abstract][Full Text] [Related]
12. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy. Aparicio AM; Elkhouiery AB; Quinn DI Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619 [TBL] [Abstract][Full Text] [Related]